Next Generation Sequencing Informatics

Next Generation Sequencing (NGS) Informatics Market to be Worth $4.3 Billion by 2030

Global NGS Informatics Market - 2023 to 2030 Meticulous Research has released a comprehensive report titled "Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030." According to this latest publication, the NGS informatics market is anticipated to reach $4.3 billion by 2030, growing at a CAGR of 15.4% during the forecast period. The market's expansion is fueled by increasing R&D investments by pharmaceutical and biotechnology companies, rising prevalence of cancer and genetic disorders, growing use of NGS in disease diagnostics and precision medicine, advancements in NGS informatics technologies, and supportive government initiatives for large-scale genomic sequencing projects. However, concerns regarding data confidentiality are hindering market growth. The increasing adoption of NGS informatics tools in hospitals and clinical laboratories and the rising use of bioinformatics and genomic data management solutions for large-scale data analysis are expected to provide growth opportunities for market players. Conversely, the shortage of skilled professionals needed to operate NGS informatics tools presents a significant challenge for market growth. Next Generation Sequencing (NGS) Informatics Market: Future Outlook The NGS informatics market is segmented based on Offering (Software [Data Analysis Software, Data Interpretation and Reporting Tools, Data Storage and Computing Tools, Laboratory Page 1 of 3 Meticulous Research| sales@meticulousresearch.com

Global NGS Informatics Market - 2023 to 2030 Information Management Systems {LIMS}], Deployment Mode [Web and Cloud-based, On- premise], NGS Informatics Services); Application (Disease Diagnoses, Biomarker Discovery, Drug Discovery, Precision Medicine, Agriculture and Animal Research); End User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic & Research Institutes, Other End Users); and Geography. The study evaluates industry competitors and analyzes the market at regional and country levels. Offering Insights In 2023, the software segment is expected to dominate the NGS informatics market, driven by the benefits of software in processing, storing, and sharing large volumes of NGS and genomic datasets with higher scalability, speed, and security. The growing demand for scalable genomic data storage further contributes to the segment's large market share. Application Insights The market is divided into disease diagnoses, biomarker discovery, drug discovery, precision medicine, agriculture, and animal research. In 2023, the drug discovery segment is projected to hold the largest market share. Factors such as the decreasing cost of sequencing per base, the ability of NGS informatics solutions to uncover numerous mutations linked to genetic diseases, and increased R&D expenditure for new drug discovery drive the segment's growth. End User Insights The NGS informatics market is segmented into pharmaceutical & biotechnology companies, hospitals and diagnostic laboratories, academic & research institutes, and other end users. In 2023, pharmaceutical & biotechnology companies are expected to lead the market due to the increasing use of sequencing information, high R&D activities, rising outsourcing of R&D projects to CROs, and decreasing sequencing costs. Geographic Review The report analyzes major regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2023, North America is expected to dominate the NGS informatics market, followed by Europe and Asia-Pacific. The U.S. is projected to be the largest market in North America, driven by increasing R&D expenditure, the presence of leading market players, favorable government initiatives, growing applications of NGS-based research, and a favorable reimbursement scenario for NGS-based tests. Page 2 of 3 Meticulous Research| sales@meticulousresearch.com

Global NGS Informatics Market - 2023 to 2030 Key Players The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.). Download Sample Report Here @ https://www.meticulousresearch.com/download- sample-report/cp_id=3483 Key questions answered in the report: Which are the high-growth market segments in terms of offering, application, end user, and region/country? What was the historical market size for next generation sequencing (NGS) informatics across the globe? What are the market forecasts and estimates for the period 2023 2030? What are the major drivers, restraints, challenges, and opportunities in the global next generation sequencing (NGS) informatics market? Who are the major players in the global next generation sequencing (NGS) informatics market? How is the competitive landscape, and who are the market leaders in the global next generation sequencing (NGS) informatics market? What are the recent developments in the next generation sequencing (NGS) informatics market? What are the different strategies adopted by the major players in the next generation sequencing (NGS) informatics market? What are the geographical trends and high growth regions/countries? Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 3 of 3 Meticulous Research| sales@meticulousresearch.com